drugset / Trial / NCT00591422
Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas
NaSingle-groupOpen-labelTreatment
Summary
The study of Dariniparsin (ZIO-101-C) in Advanced Solid Tumors and Non-Hodgkin's Lymphomas
Timeline
- Start
- 2007-08
- Primary completion
- 2010-03-10
- Completion
- 2011-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darinaparsin | Small molecule | 100 mg | Oral |
| Subject | Darinaparsin | Small molecule | 1000 mg | Oral |